MedPath

Outcome Analysis of POEM and Endoluminal Therapies

Not Applicable
Conditions
Gastric Fistula
Achalasia
Stenoses
Weight Gain After Primary Weight Loss Surgery
Gastric Nec
Marginal Ulcer
Interventions
Procedure: Endoscopic Intervention
Registration Number
NCT03123835
Lead Sponsor
University of California, Davis
Brief Summary

Evaluation of current and newly developed endoluminal therapies in the management of Upper and Lower GI conditions.

Detailed Description

Over the last few years there have been numerous advances in the use of endoscopic equipment and related treatments in the identification and intervention of gastrointestinal diseases. Many of these treatments using flexible endoscopes have either complimented or replaced surgical approaches to these same benign and malignant disease processes with the potential of being the standard of care for many of these clinical conditions. The initial primary focus of this study will be the use of endoscopic myotomy for achalasia, endoscopic treatment of post bariatric weight gain, endoscopic gastro-gastric fistula treatments, and other endoluminal therapies for gastrointestinal and post-operative conditions. These treatments have been validated by prior surgery studies.

Recruitment & Eligibility

Status
ENROLLING_BY_INVITATION
Sex
All
Target Recruitment
500
Inclusion Criteria
  • Adult male and female patients 18-80 years of age
  • Meet the criteria for surgery of benign and/or malignant gastrointestinal pathology(s)
  • Gastrointestinal Reflux Disease
  • Achalasia
  • Barrett's Esophagus
  • Post Bariatric Surgery conditions
  • Other gastrointestinal and postsurgical disorders.
Read More
Exclusion Criteria
  • Adults unable to consent
  • Individuals that do not meet inclusion criteria or qualify for endoluminal treatment paradigms and internees.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
TreatmentEndoscopic InterventionPatients meeting inclusion criteria for possible surgical therapies for their current condition (IE Achelasia, Enlarged Gastric Pouch and/or Gastrogastric Fistula after primary weight loss surgery, etc) will be educated on the different therapy options including traditional laparoscopic surgery and/or Endoscopic Interventions including POEM (Percutaneous Oral Endoscopic Myomectomy for the treatment of Achelasia) or Endoscoscopic Pouch/GastroJejunostomy repair or closure of the Gastrogastric Fistula as examples.
Primary Outcome Measures
NameTimeMethod
Decrease in GERDDQ3-6 months

Assessment will be made via post surgery questionnaire (decreasing in scoring will be 0-5)

Secondary Outcome Measures
NameTimeMethod
Decrease in Eckardt scoring30 days

Decrease in overall GERD symptoms using Eckardt Scoring methodology (5-0)

Trial Locations

Locations (1)

Univesity of California Davis Health System

🇺🇸

Sacramento, California, United States

© Copyright 2025. All Rights Reserved by MedPath